Cargando…
Combined systemic and ocular chemotherapy for anterior segment metastasis of systemic mantle cell lymphoma
BACKGROUND: Mantle cell lymphoma (MCL) is an aggressive subtype of non-Hodgkin’s lymphoma that rarely metastasizes to the iris and the anterior segment. Blastic/pleomorphic morphology is thought to have an adverse effect on prognosis in MCL. MCL is resistant to conventional chemotherapeutic regimens...
Autores principales: | Agarwal, Aniruddha, Sadiq, Mohammad Ali, Rhoades, William R., Jack, Loren S., Hanout, Mostafa, Bierman, Philip J., West, William W., Nguyen, Quan Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598336/ https://www.ncbi.nlm.nih.gov/pubmed/26450638 http://dx.doi.org/10.1186/s12348-015-0060-1 |
Ejemplares similares
-
Management of neovascular age-related macular degeneration: current state-of-the-art care for optimizing visual outcomes and therapies in development
por: Agarwal, Aniruddha, et al.
Publicado: (2015) -
Choroidal and Ocular Adnexal Lymphoma Extension From Systemic Mantle Cell Lymphoma: A Case Report
por: Bou Ghanem, Ghazi O., et al.
Publicado: (2021) -
Mantle Cell Lymphoma and Involvement of the Orbit and Ocular Adnexa
por: Vali Khojeini, Elham, et al.
Publicado: (2013) -
Platelet derived growth factor inhibitors: A potential therapeutic approach for ocular neovascularization
por: Sadiq, Mohammad Ali, et al.
Publicado: (2015) -
High-resolution adaptive optics findings in talc retinopathy
por: Soliman, Mohamed K, et al.
Publicado: (2015)